Work

Phase I, Open-Label, Dose-Escalating Study of a Genetically Engineered Herpes Simplex Virus, NV1020, in Subjects with Metastatic Colorectal Carcinoma to the Liver

Year: 2006

Type: article

Study design: Clinical Trial

Source: Human Gene Therapy

DOI: 10.1089/hum.2006.17.1214

Authors: Nancy Kemeny, Karen Brown, Anne Covey, Teresa Kim, Amit Bhargava, Lynn Brody, Brenda Guilfoyle, Natasha P. Haag, Matthias Karrasch, Birgit Glasschroeder, Anette Knoll, George Getrajdman, K. Jon Kowal, William R. Jarnagin, Yuman Fong

Institutions: Memorial Sloan Kettering Cancer Center, George Washington University, Medigene (Germany)

Language: English

Topic: Virus-based gene therapy research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2158058958

FWCI: 9.117

Cites: 41

Cited by: 172

Related to: 10